GEORGE A APERGIS

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease BROOKLYN, NY NPI 1760657183

General Payments — all program years on this page

$4,178.46

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 167
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $475.09 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $475.0920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $192.949
2019 $703.1824
2020 $528.3724
2021 $745.4829
2022 $638.7423
2023 $894.6638
2024 $475.0920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078105636 Janssen Pharmaceuticals, Inc $15.72 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104249519 AstraZeneca Pharmaceuticals LP $26.06 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104521386 AstraZeneca Pharmaceuticals LP $20.87 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104577548 AstraZeneca Pharmaceuticals LP $19.72 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104732609 AstraZeneca Pharmaceuticals LP $20.95 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105399142 AstraZeneca Pharmaceuticals LP $24.24 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105474569 AstraZeneca Pharmaceuticals LP $20.69 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105505796 AstraZeneca Pharmaceuticals LP $27.40 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105823261 AstraZeneca Pharmaceuticals LP $26.34 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111518347 Amgen Inc. $19.50 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111518349 Amgen Inc. $26.60 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111518351 Amgen Inc. $25.82 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116354493 GlaxoSmithKline, LLC. $25.71 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116390578 GlaxoSmithKline, LLC. $21.32 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118854112 Otsuka America Pharmaceutical, Inc. $28.46 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118854114 Otsuka America Pharmaceutical, Inc. $28.04 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118854116 Otsuka America Pharmaceutical, Inc. $13.55 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130951049 PFIZER INC. $18.54 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144987220 INOGEN, INC. $21.84 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146878887 Philips North America LLC $43.72 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.